Shinzaburo Noguchi

22.2k total citations · 3 hit papers
389 papers, 13.7k citations indexed

About

Shinzaburo Noguchi is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Shinzaburo Noguchi has authored 389 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 194 papers in Oncology, 177 papers in Cancer Research and 122 papers in Molecular Biology. Recurrent topics in Shinzaburo Noguchi's work include Breast Cancer Treatment Studies (122 papers), Estrogen and related hormone effects (82 papers) and Cancer Treatment and Pharmacology (62 papers). Shinzaburo Noguchi is often cited by papers focused on Breast Cancer Treatment Studies (122 papers), Estrogen and related hormone effects (82 papers) and Cancer Treatment and Pharmacology (62 papers). Shinzaburo Noguchi collaborates with scholars based in Japan, United States and Canada. Shinzaburo Noguchi's co-authors include Yasuhiro Tamaki, Yasuo Miyoshi, Tetsuya Taguchi, Kenzo Shimazu, Seung Jin Kim, Hideo Inaji, Kazuyoshi Motomura, Chiyomi Egawa, Tomonori Tanei and Yasuto Naoi and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shinzaburo Noguchi

375 papers receiving 13.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2

2014 407 citations Martine Piccart, Gabriel N. Hortobágyi et al. profile →
Fulvestrant 500 mg versus anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON): an international, randomised, double-blind, phase 3 trial

2016 384 citations J.F.R. Robertson, Zhimin Shao et al. profile →
Everolimus Plus Exemestane in Postmenopausal Patients with HR+ Breast Cancer: BOLERO-2 Final Progression-Free Survival Analysis

2013 383 citations Shinzaburo Noguchi, Kathleen I. Pritchard et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shinzaburo Noguchi Japan	64	6.1k	5.2k	5.1k	2.8k	2.5k	389	13.7k
Joseph Geradts United States	55	6.5k 1.1×	5.1k 1.0×	5.1k 1.0×	2.1k 0.8×	1.9k 0.7×	195	12.8k
Celina G. Kleer United States	65	7.9k 1.3×	5.8k 1.1×	9.2k 1.8×	1.9k 0.7×	1.3k 0.5×	174	17.2k
Stan B. Kaye United Kingdom	65	9.5k 1.6×	3.6k 0.7×	8.7k 1.7×	4.2k 1.5×	2.1k 0.9×	217	19.2k
Nobuyuki Arima Japan	26	6.3k 1.0×	6.0k 1.2×	5.7k 1.1×	2.4k 0.9×	1.7k 0.7×	86	13.4k
Karin Jirström Sweden	59	6.2k 1.0×	3.9k 0.7×	5.9k 1.1×	2.1k 0.8×	1.1k 0.4×	316	13.3k
Ronald Simon Germany	63	5.2k 0.9×	3.4k 0.7×	6.9k 1.3×	3.9k 1.4×	1.3k 0.5×	357	13.5k
François Bertucci France	72	8.9k 1.5×	5.4k 1.1×	7.5k 1.5×	4.8k 1.8×	1.1k 0.4×	515	18.8k
Bryan T. Hennessy Ireland	59	9.0k 1.5×	6.4k 1.2×	9.7k 1.9×	3.0k 1.1×	1.7k 0.7×	266	19.8k
Reiki Nishimura Japan	27	6.8k 1.1×	6.2k 1.2×	5.4k 1.1×	2.6k 0.9×	1.8k 0.7×	131	13.3k
Maria Grazia Daidone Italy	59	6.2k 1.0×	5.6k 1.1×	8.0k 1.6×	1.5k 0.6×	1.2k 0.5×	279	14.6k

Countries citing papers authored by Shinzaburo Noguchi

Since Specialization

Citations

This map shows the geographic impact of Shinzaburo Noguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinzaburo Noguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinzaburo Noguchi more than expected).

Fields of papers citing papers by Shinzaburo Noguchi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinzaburo Noguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinzaburo Noguchi. The network helps show where Shinzaburo Noguchi may publish in the future.

Co-authorship network of co-authors of Shinzaburo Noguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Shinzaburo Noguchi. A scholar is included among the top collaborators of Shinzaburo Noguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shinzaburo Noguchi. Shinzaburo Noguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sato, Yasufumi, Masafumi Shimoda, Tomohiro Miyake, et al.. (2021). Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody. Cancer Medicine. 10(4). 1418–1430. 9 indexed citations

Naoi, Yasuto, Masafumi Shimoda, Tomonori Tanei, et al.. (2021). Impact of tumor cellularity on the HER2 amplification assay by OncoScan™ in breast cancer. Breast Cancer. 28(4). 977–982.

Pradipta, Ambara R., Tomonori Tanei, Koji Morimoto, et al.. (2019). Tetramethylrhodamine is an essential scaffold of azide probe in detecting cellular acrolein. Bioorganic & Medicinal Chemistry. 27(11). 2228–2234. 17 indexed citations

Miyake, Tomohiro, Kenzo Shimazu, Tomonori Tanei, et al.. (2019). Hookwire-guided Sentinel Lymph Node Biopsy Using Contrast-enhanced Ultrasonography Followed by a One-step Nucleic Acid Amplification (OSNA) Assay for Breast Cancer. Anticancer Research. 39(11). 6183–6192. 7 indexed citations

Noguchi, Shinzaburo, Matthew J. Ellis, J.F.R. Robertson, et al.. (2018). Progression-free survival results in postmenopausal Asian women: subgroup analysis from a phase III randomized trial of fulvestrant 500 mg vs anastrozole 1 mg for hormone receptor-positive advanced breast cancer (FALCON). Breast Cancer. 25(3). 356–364. 12 indexed citations

Shimoda, Masafumi, Naofumi Kagara, Yasuto Naoi, et al.. (2016). Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer. Breast Cancer Research and Treatment. 157(1). 55–63. 40 indexed citations

Gnant, Michael, José Baselga, Hope S. Rugo, et al.. (2013). Effect of Everolimus on Bone Marker Levels and Progressive Disease in Bone in BOLERO-2. JNCI Journal of the National Cancer Institute. 105(9). 654–663. 77 indexed citations

Fujita, Noriko, Takahiro Nakayama, Noriaki Yamamoto, et al.. (2012). Methylated DNA and Total DNA in Serum Detected by One-Step Methylation-Specific PCR Is Predictive of Poor Prognosis for Breast Cancer Patients. Oncology. 83(5). 273–282. 49 indexed citations

Miyoshi, Yasuo, Masafumi Kurosumi, Junichi Kurebayashi, et al.. (2009). Predictive factors for anthracycline-based chemotherapy for human breast cancer. Breast Cancer. 17(2). 103–109. 13 indexed citations

10.

Inoue, Kenichi, Kazuhiko Nakagami, Mitsuhiro Mizutani, et al.. (2009). Randomized phase III trial of trastuzumab monotherapy followed by trastuzumab plus docetaxel versus trastuzumab plus docetaxel as first-line therapy in patients with HER2-positive metastatic breast cancer: the JO17360 Trial Group. Breast Cancer Research and Treatment. 119(1). 127–136. 68 indexed citations

11.

Tanei, Tomonori, Koji Morimoto, Kenzo Shimazu, et al.. (2009). Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers. Clinical Cancer Research. 15(12). 4234–4241. 475 indexed citations

12.

Akazawa, Kenji, Yasuhiro Tamaki, Tetsuya Taguchi, et al.. (2008). Potential of Reduction in Total Tumor Volume Measured with 3D-MRI as a Prognostic Factor for Locally-Advanced Breast Cancer Patients Treated with Primary Chemotherapy. The Breast Journal. 14(6). 523–531. 16 indexed citations

13.

Miyoshi, Yasuo, Masafumi Kurosumi, Junichi Kurebayashi, et al.. (2007). Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers. Journal of Cancer Research and Clinical Oncology. 134(5). 561–567. 10 indexed citations

14.

Yano, Kenji, Ko Hosokawa, Kunihiro Nakai, et al.. (2003). Skin-sparing mastectomy and immediate reconstruction with a deep inferior epigastric perforator flap. Breast Cancer. 10(3). 275–280. 11 indexed citations

15.

Aihara, Tomohiko, Yuichi Takatsuka, Kuniaki Itoh, et al.. (2003). Phase II Study of Concurrent Administration of Doxorubicin and Docetaxel as First-Line Chemotherapy for Metastatic Breast Cancer. Oncology. 64(2). 124–130. 10 indexed citations

16.

Yoshikawa, Kiyotsugu, Tomoko Ogawa, Richard Baer, et al.. (2000). Abnormal expression of BRCA1 and BRCA1-interactive DNA-repair proteins in breast carcinomas. International Journal of Cancer. 88(1). 28–36. 77 indexed citations

17.

Hashimoto, Kazumasa, Chihiro Azuma, Shoji Kamiura, et al.. (1995). Clonal Determination of Uterine Leiomyomas by Analyzing Differential Inactivation of the X-Chromosome-Linked Phosphoglycerokinase Gene. Gynecologic and Obstetric Investigation. 40(3). 204–208. 77 indexed citations

18.

Inaji, Hideo, Hidenori Koyama, Kazuyoshi Motomura, et al.. (1993). ErbB-2 Protein Levels in Nipple Discharge: Role in Diagnosis of Early Breast Cancer. Tumor Biology. 14(5). 271–278. 18 indexed citations

19.

Noguchi, Shinzaburo, Hideaki Tahara, Keisuke Miyauchi, & Hiroki Koyama. (1989). Influence of 1α,25-Dihydroxy vitamin D<sub>3</sub> on the Development and Steroid Hormone Receptor Contents of DMBA-Induced Rat Mammary Tumors. Oncology. 46(4). 273–276. 5 indexed citations

20.

Matsumoto, Keishi, et al.. (1985). Endocrine therapy in cancer.. 22(8). 1057–1065.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact